Skip to main content
홈
소개
연락처
유용한 리소스
More…
Posts
Showing posts with the label
FDA
Show all
July 13, 2021
Breakthrough or Breakdown? Aducanumab’s Approval by the FDA with Comments from Neurologist Dr. Allan Levey
July 06, 2021
Aduhelm Puts Patients At The Helm, But At What Cost?
August 11, 2020
Alzheimer’s Disease and the FDA: Two Things To Watch
January 28, 2020
CBD for Your Anxiety: Ethical Concerns
June 14, 2016
Consumer Neurotechnology: New Products, More Regulatory Complexity
September 01, 2015
Brain devices: Navigating collaborations between industry, government, and researchers
June 17, 2014
Predicting Alzheimer’s Disease: Potential Ethical, Legal, and Social Consequences
October 03, 2012
The Army’s on Ecstasy: Marching toward an ethical drug policy
Older Posts
Home
Emory Neuroethics on Facebook
